CXCL1 stimulates migration and invasion in ER‑negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis
Chengcheng Yang(Harbin Medical University), Shengchun Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Cited by 76
Related Papers
Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence
|Oncogene|2016|430
Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor
|Oncology Reports|2019|223
HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance
|Oncology Reports|2021|30
Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancer
|International Journal of Oncology|2020|24
GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway
|International Journal of Oncology|2024|20